Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
- 1 August 2007
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 62 (2), 145-153
- https://doi.org/10.1002/ana.21192
Abstract
Objective Parkinson's disease (PD) is a neurodegenerative condition that typically presents as a movement disorder but is known to be associated with variable degrees of cognitive impairment including dementia. We investigated the genetic basis of susceptibility to and cognitive heterogeneity of this disease. Methods In 659 PD patients, 109 of which were followed up for 3.5 years from diagnosis, and 2,176 control subjects, we studied candidate genes involved in protein aggregation and inclusion body formation, the pathological hallmark of parkinsonism: microtubule‐associated protein tau (MAPT), glycogen synthase kinase‐3β (GSK3B), and α‐synuclein (SNCA). Results We observed that cognitive decline and the development of PD dementia are strongly associated (p = 10−4) with the inversion polymorphism containing MAPT. We also found a novel synergistic interaction between the MAPT inversion polymorphism and the single nucleotide polymorphism rs356219 from the 3′ region of SNCA. In our data, carrying a risk genotype at either of these loci marginally increases the risk for development of PD, whereas carrying the combination of risk genotypes at both loci approximately doubles the risk for development of the disease (p = 3 × 10−6). Interpretation Our data support the hypothesis that tau and α‐synuclein are involved in shared or converging pathways in the pathogenesis of PD, and suggest that the tau inversion influences the development of cognitive impairment and dementia in patients with idiopathic PD. These findings have potentially important implications for understanding the interface between tau and α‐synuclein pathways in neurodegenerative disorders and for unraveling the biological basis for cognitive impairment and dementia in PD. Ann Neurol 2007Keywords
This publication has 42 references indexed in Scilit:
- Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyThe Lancet Neurology, 2006
- Genomewide Association, Parkinson Disease, and PARK10American Journal of Human Genetics, 2006
- Conflicting Results Regarding the Semaphorin Gene (SEMA5A) and the Risk for Parkinson DiseaseAmerican Journal of Human Genetics, 2006
- No Evidence for Association with Parkinson Disease for 13 Single-Nucleotide Polymorphisms Identified by Whole-Genome Association ScreeningAmerican Journal of Human Genetics, 2006
- A Case-Control Association Study of the 12 Single-Nucleotide Polymorphisms Implicated in Parkinson Disease by a Recent Genome ScanAmerican Journal of Human Genetics, 2006
- Interface between tauopathies and synucleinopathies: A tale of two proteinsAnnals of Neurology, 2006
- GSK3B polymorphisms alter transcription and splicing in Parkinson's diseaseAnnals of Neurology, 2005
- High-Resolution Whole-Genome Association Study of Parkinson DiseaseAmerican Journal of Human Genetics, 2005
- Molecular genetic pathways in Parkinson's disease: a reviewClinical Science, 2005
- Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanismsAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005